Application

16045346 · TARGETED PROTEIN DEGRADATION USING A MUTANT E3 UBIQUITIN LIGASE

Filed 2018-07-25 · Granted · Patent 10239888 (2019-03-26) The official file ↗The patent and its PDF ↗ · Art unit 1626 · Examiner Nyeemah A Grazier Typical · CPC C07D 495/14 · Dana-Farber Cancer Institute, Inc. · ArentFox Schiff, LLP & DFCI

Office actions

first was Notice of allowance

RCEs

no appeal

To first action

3.2 mo

to disposition 8.0 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.